NeoCore Technology , Ltd. EBIT

NeoCore Technology , Ltd. (4131.TWO) currently reports a EBIT of $-30M as of June 2026. That compares with $-17M in the prior-year period — down 74.7% year over year. That is below the Healthcare sector average of $130B. Use the charts on this page to explore NeoCore Technology , Ltd.'s EBIT history and peer comparisons.

NeoCore Technology , Ltd.'s EBIT decreased from $-17M to $-30M — a 74.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NeoCore Technology , Ltd.'s EBIT of $-30M is lower than the Healthcare sector average of $130B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

NeoCore Technology , Ltd. reported $-30M in EBIT as of June 2026. That compares with $-17M in the prior-year period — down 74.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-30M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $130B. From there, open related valuation or income-statement pages for NeoCore Technology , Ltd., and consider following 4131.TWO for alerts when major investors trade the stock.